diazepam and cc-223

diazepam has been researched along with cc-223 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beaufils, F; Bohnacker, T; Borsari, C; Burke, J; Fabbro, D; Hebeisen, P; Hillmann, P; Langlois, JB; Löscher, W; Melone, A; Rageot, D; Sele, AM; Wymann, MP; Zvelebil, M	1

Other Studies

1 other study(ies) available for diazepam and cc-223

Article	Year
Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders. Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22 Topics: Animals; Azabicyclo Compounds; Blood-Brain Barrier; Cell Line, Tumor; Cell Proliferation; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Models, Molecular; Phosphatidylinositol 3-Kinases; Protein Conformation; Pyridines; Rats; Seizures; Triazines	2018

Article

Year

Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders.

Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

Topics: Animals; Azabicyclo Compounds; Blood-Brain Barrier; Cell Line, Tumor; Cell Proliferation; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Models, Molecular; Phosphatidylinositol 3-Kinases; Protein Conformation; Pyridines; Rats; Seizures; Triazines

2018